Mezomib 2mg

Bortezomib is a type of targeted cancer drug called a proteasome inhibitor.

Proteasomes are in cells.

They help to break down and remove proteins that the cell doesn't need.

Cells need proteasomes to grow and develop.

Bortezomib blocks the function of the proteasomes so the proteins build up inside the cell.

Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications. It is given by injection.